Barely Significant
← all excerpts

Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database.

Front Oncol · 2018 · PMC6252384 · PMID 30510914

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantP < 0.0001actually significant
This study did not show a benefit in OS (adjusted HR 0.78, 95% CI.0.56–1.08; P = 0.13), but did reveal a highly significant improvement in PFS, with 5 year PFS of 47.6 vs. 31.8% for those given immediate adjuvant chemotherapy (HR: 0.54, 95% CI: 0.40–0.73, P < 0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.